MUSTGROW BIOLOGICS CORP.
Commented by Armin Schulz on September 10th, 2026 | 06:50 CEST
Brussels Is Driving the Billion-Dollar Fertilizer Market: Can Bayer, MustGrow Biologics and K+S Benefit?
Created and Published on Behalf of MustGrow Biologics Corp.
Agriculture is in crisis, creating a billion-dollar market that few investors can afford to ignore. Brussels is imposing ever tighter restrictions on chemical crop protection products in Europe, while soils around the world are becoming increasingly depleted. Those still relying on conventional fertilizers today risk falling behind in the long run. Demand is rising for organic crop protection products and fertilizers that deliver high yields while still meeting environmental requirements. Three stocks show how differently investors can profit from the biological revolution in soil health: Bayer, MustGrow Biologics, and K+S.
Read
Commented by Fabian Lorenz on September 9th, 2026 | 07:00 CEST
Evotec Under Pressure! Analysts See Upside Potential - News From MustGrow and Bayer
Created and Published on Behalf of MustGrow Biologics Corp.
Alarm bells are ringing at Evotec. The share price is at risk of slipping below the EUR 3 mark. Even at this seemingly low price level, analysts are notably reluctant to issue "Buy" recommendations. Evotec has, however, announced a research collaboration to develop new T-cell-activating therapeutic approaches for solid tumors. MustGrow's story is now gaining noticeable momentum. The Canadian AgTech company reached profitability in the first half of the year and expects revenue to increase in the second half. In addition, the first milestone payment from Bayer under their licensing agreement has been received. Further payments running into the millions could follow in the coming years and exceed MustGrow's current market capitalization. Analysts see potential for significant upside. Bayer itself has announced an intensive phase of new product launches for its Crop Science division. Analysts recommend buying the stock.
Read
Commented by Tarik Dede on September 5th, 2026 | 05:00 CEST
Three Stocks for a Speculative Portfolio: SanDisk, MustGrow Biologics and Super Micro Computer
Created and Published on Behalf of MustGrow Biologics Corp.
Conservative investors tend to favour cash-generative stocks and dividend payers. However, every portfolio should also have a little spice. After all, blue-chip stocks do not always deliver outperformance, although they often provide greater stability. These additional returns can come from both small and large companies. At present, concerns about higher interest rates are weighing on many of the high-flyers of recent months and years. Some stocks have suffered significant pullbacks, even though their outlook remains bright. Today, we therefore take a look at three more speculative but high-growth stocks: SanDisk, MustGrow Biologics and Super Micro Computer.
Read
Commented by Stefan Bode on September 4th, 2026 | 10:40 CEST
Billion-Dollar Contracts, Takeover Battle and 600% Upside Potential: Where the Action Is Now - Frasers Group, Hugo Boss, MustGrow Biologics, OHB
Created and Published on Behalf of MustGrow Biologics Corp.
Pure excitement and volatility on the international financial markets. While an established, long-standing group faces a change in control following a takeover bid and a battle for majority voting rights, an emerging niche player is celebrating its first-ever quarterly profit following a groundbreaking deal with a major player in the agricultural sector. At the same time, a high-profile technology leader is showing that even significant billion-dollar contracts offer no guarantee of a rising share price. Three highly exciting companies from different sectors offer unique opportunities for your investment portfolio.
Read
Commented by André Will-Laudien on August 26th, 2026 | 10:00 CEST
The Focus Is on Nutrition, Not Microchips: What Is on the Menu at McDonald's, Bayer, MustGrow and Kraft Heinz?
Created and Published on Behalf of MustGrow Biologics Corp.
The stock market is many things, but it is hardly sustainable. Trends change as quickly as the weather—chips are all the rage today, but tomorrow they are out of favor. Funnily enough, the lines of reasoning are similar whether the market is rising or falling. However, sustainability is of paramount importance in the food production sector and among publicly traded companies in it. This is because a consistent ESG focus in global food production has evolved from a mere image factor to an established guarantee of success. A recent study by the McKinsey Global Institute impressively demonstrates that companies with strong ESG structures have more resilient supply chains in the long term and enjoy significantly higher consumer loyalty. Giants like McDonald's and Kraft Heinz are driving this transformation by increasingly focusing on recyclable packaging, nature-based farming, and ethical sourcing of raw materials. However, this green transition would be virtually inconceivable without innovative suppliers and trailblazers at the base of the value chain. This is where the agricultural giant Bayer comes into play, laying the foundation for lower-emission crops through targeted investments in biological crop protection and regenerative agriculture. As an agile driver of innovation, the Canadian company MustGrow Biologics is tapping into this trend and revolutionizing the market with all-natural active ingredients derived from the mustard plant. It is worth taking a closer look at what really matters!
Read
Commented by Nico Popp on August 25th, 2026 | 07:00 CEST
Goodbye to Chemical Pesticides: Bayer Partner MustGrow Biologics Makes Progress – Has Bioceres Overreached?
Created and Published on Behalf of MustGrow Biologics Corp.
Agriculture is at a turning point. Strict environmental regulations are increasingly pushing chemical crop-protection products off the fields. At the same time, the effects of climate change are creating additional challenges. This puts farmers in a difficult position: on the one hand, they need to secure yields, while on the other, they must comply with increasingly stringent regulations. The solution could lie in biological alternatives to conventional chemical pesticides. This market is growing rapidly and opening up opportunities for innovative companies. We take a look at the latest trends and highlight some exciting companies.
Read
Commented by Matthias Schomber on August 24th, 2026 | 07:30 CEST
Return Opportunities in Defence, Hydrogen and GreenTech: How Deutz, Nel ASA and MustGrow Biologics Are Gearing Up for a Breakout!
Created and Published on Behalf of MustGrow Biologics Corp.
Trump's hard-line stance in the Iran conflict and the blockade of the Strait of Hormuz have been keeping the financial markets on edge for weeks and months. This issue will likely remain with us for quite some time. However, these geopolitical crises are currently causing massive shifts in market weightings, with defence-related stocks gaining renewed momentum while many former "hydrogen hype" stocks continue to lose ground. Deutz AG, for example, is pivoting toward the defence technology sector with billion-euro acquisitions, thereby striking exactly the right chord with current market sentiment. Nel ASA, by contrast, is experiencing the opposite: despite a strong order book, weak margins continue to weigh on the stock. Away from these two companies, MustGrow Biologics, a smaller company operating in a niche market, is making headway. The Canadian agri-biotech specialist is making strides in sustainable crop protection and may be on the verge of a technical breakout.
Read
Commented by Stefan Bode on August 20th, 2026 | 07:30 CEST
Stock Market Reality Check: When the Numbers Alone Are No Longer Enough – Infineon, Klarna and MustGrow Biologics
Created and Published on Behalf of MustGrow Biologics Corp.
Between sharp sell-offs and opportunities to scale, it becomes clear just how quickly the stock market reassesses expectations. One company suddenly delivers profits—and is still punished because its outlook turns lower. A growth stock must raise fresh capital to meet strong demand. And in the cyclical semiconductor industry, solid quarterly results are often not enough when bond yields rise and risk appetite shifts. For investors looking to understand what is really driving these market moves, the underlying pattern becomes clear.
Read
Commented by André Will-Laudien on August 12th, 2026 | 08:05 CEST
Heat, Drought, and Water Shortages: A Sector-Wide Buy Signal for Environmental Specialists Bayer, MustGrow, Kraft Heinz and Unilever
Created and Published on Behalf of MustGrow Biologics Corp.
The devastating combination of persistent drought, acute water shortages, and extreme heat is creating unprecedented challenges for the global economy and food supply. As climate-related risks intensify, ESG considerations are moving into sharper focus than ever before. Amid this crisis, a potential technical and fundamental buy signal is emerging across sectors for companies capable of delivering innovative environmental solutions. Agricultural and chemical companies such as Bayer are developing advanced seed technologies designed to make crops more resilient during periods of extreme drought. At the same time, the AgriTech company MustGrow is gaining importance as its biological fertilizer and crop protection solutions are designed to protect soil health and improve water efficiency in agriculture, among other things. Food giants such as Unilever and Kraft Heinz are also responding proactively by strictly optimizing their entire supply chains to minimize water consumption and resource intensity. Investors are increasingly recognizing that sustainable business practices in modern times are no longer merely an image factor, but rather a catalyst for future returns.
Read
Commented by Fabian Lorenz on August 11th, 2026 | 07:15 CEST
Sell Rheinmetall Shares? Over 20% Gains in One Week! Buy Rating for OHB! Bayer Partner MustGrow Begins Re-Rating
Created and Published on Behalf of MustGrow Biologics Corp.
MustGrow Biologics shares climbed more than 20% last week, potentially marking the beginning of a long-awaited re-rating. Analysts believe significantly higher prices are achievable. Revenue is expected to multiply over the coming years, with the company also targeting substantial profitability. MustGrow could also benefit from milestone payments from its partner, Bayer. These potential payments are not included in current analyst estimates, potentially providing additional upside. At Rheinmetall, analysts are lowering their 2028 revenue estimates. Experts also see risks regarding cash flow and margins. As a result, they have downgraded the shares of Germany's largest defence contractor from "Hold" to "Sell." Analysts are considerably more optimistic about OHB. A key element of the investment case is the expectation that the German space-industry hopeful will secure major contracts over the coming months.
Read